INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX

File: 123096_sep96_decls12_0015.txt
Page: 0015
Total Pages: 32

Subject: INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX             

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: CAUTIONARY NOTE                                                                                 

Document Number:          2

Folder Seq  #:         14











        5. Batulinum Toxin

            a. Pre-Exposure Vaccination - Botulinum vaccine (toxoid)
        should be given in 0.5 ml doses deep subcutaneously at day 0, 14,
        and 84 with protective levels of antibodies established two weeks
        following the third dose. (Booster dose is given at one year.)

            b. Post-Exposure Treatment

                (1) The botulinum antitoxin (despeciated equine) is
        available in limited quantities for the treatment of botulinum-
        exposed patients. Antitoxin is available for treatment only; it
        will be given only to symptomatic patients or members of cohort
        units judged to be definitely exposed but who may be
        presymptonatic. Antitoxin is administered under protocol
        intravenously.

                (2) Decision to use botulinum antitoxin is made by medical
        authorities.





































                                          2

Document 32 f:/Week-36/BX003201/CAUTIONARY NOTE/interim medical doctrine bw defense against anth:12179609280113
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = CAUTIONARY NOTE
Folder Seq # = 14
Subject = INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTH
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996